Today: 27 June 2026
Mastercard stock slides to $518 as Wall Street heads into Presidents Day break
15 February 2026
1 min read

Mastercard stock slides to $518 as Wall Street heads into Presidents Day break

New York, February 15, 2026, 14:28 (EST) — Market’s done for the day.

  • Mastercard dropped 1.73% on Friday, closing at $518.36. That marked the third straight session of losses for the stock.
  • Visa dropped harder, but the broader U.S. market ended the day mostly flat
  • U.S. stock markets will stay closed Monday for Presidents Day. Trading picks back up on Tuesday.

Shares of Mastercard Incorporated slipped 1.73% to $518.36 on Friday, capping off a three-day slide and lagging behind a largely flat U.S. market. Trading volume surpassed the 50-day average. The stock wrapped up the session sitting roughly 14% below its 52-week high, according to MarketWatch.

The calendar’s key here: U.S. exchanges will go dark Monday for Washington’s Birthday, or Presidents Day, leaving Wall Street with an extra-long weekend. That pushes the next cash session out until Tuesday—raising the odds for thinner liquidity and possibly bigger price swings when markets snap back.

MA’s recent slide is turning attention squarely to the next data on rates and consumer spending—key signals that can quickly move card volumes. Now, investors are weighing whether Friday’s drop was something unique to the stock or just another dip across payments stocks.

The S&P 500 eked out a 0.05% gain Friday, with the Dow rising 0.10%. The Nasdaq dropped 0.22%. Earlier, stocks had shown some strength after January U.S. inflation figures landed softer than anticipated—enough to push up bets on a June rate cut. But heading into the three-day weekend, caution took hold. “Any whiff of optimism” was being snuffed out, said Michael James at Rosenblatt Securities. Reuters

Shares of Mastercard kicked off Friday’s session at $529.06, before swinging between $533.99 at the top and $516.02 at the low, and finally settling at $518.36, Yahoo Finance data showed.

Other payments stocks took a bigger hit. Visa slid 3.12% Friday, while American Express lost roughly 1.6%, weighing down the payments and credit card space even as the main indexes stayed steady.

Fees are never far from investors’ minds. Visa and Mastercard floated a new $38 billion settlement with merchants last year to address interchange, or “swipe,” fees—the costs retailers shoulder every time a customer swipes a card. Any change in how much control the networks have over pricing still hangs over the sector. Reuters

This arrangement can reverse in a hurry. Should rate-cut odds fade, high-multiple stocks are likely to feel it first. On the other hand, weaker consumer demand may dent transaction growth and cross-border spending ahead of showing up in overall earnings.

Once the market reopens, eyes will be on MA to see if it can hold above Friday’s $516 low. Traders are also watching if the sector’s lag starts to close. The next scheduled highlight lands Wednesday, when the Federal Reserve releases minutes from its January 27–28 policy meeting — a document that’s often dissected for hints about future rate moves.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Telix Pharmaceuticals and Two Australian Insider-Led Growth Stocks Highlighted
    June 27, 2026, 11:07 AM EDT. Telix Pharmaceuticals (ASX:TLX), a A$5.2 billion biopharmaceutical firm specializing in radiopharmaceuticals for cancer imaging and treatment, draws growth-focused investors despite ongoing losses. The company reported US$621.9 million revenue from Precision Medicine and relies heavily on its oncology pipeline with products like Illuccix and late-stage candidates TLX591 and TLX101. Key risks include high R&D costs, regulatory scrutiny, pricing pressures, and trial dependencies. Also featured are two Australian insider-led growth stocks identified by the Fast Growing Stocks With High Insider Ownership screener, highlighting firms with aligned management-shareholder interests amid mixed inflation and cautious central bank policies.

Latest articles

GameStop (NYSE:GME) holds close to cash levels after company guides for $600 million in EBITDA

GameStop (NYSE:GME) holds close to cash levels after company guides for $600 million in EBITDA

27 June 2026
GameStop surged 3.57% to $21.76 and jumped after hours as it forecast FY2026 adjusted EBITDA above $600 million, nearly doubling from 2025; with a $9.76 billion market cap now close to its $9.7 billion in cash, securities, digital assets, and collateral, investors are weighing whether GameStop’s cash-rich balance sheet can support equity while Ryan Cohen pursues an eBay bid.
ImmunityBio (NASDAQ:IBRX) trades after post-Russell spike with 46% more volume

ImmunityBio (NASDAQ:IBRX) trades after post-Russell spike with 46% more volume

27 June 2026
ImmunityBio surged 11.8% to $8.71 on Friday with volume tripling its average, as Russell index reconstitution took effect; Monday’s trading will reveal if demand persists or if the spike was driven by index flows, with no imminent company events and recent insider selling accounting for just 0.06% of Friday’s volume.
Lucid (NASDAQ:LCID) jumps, adding about $312 million after $158 million cost plan

Lucid (NASDAQ:LCID) jumps, adding about $312 million after $158 million cost plan

27 June 2026
Lucid surged 15.6% Friday, adding $312 million in equity value—almost double the $158 million in annualized savings from this week’s restructuring plan that cut 18% of its U.S. workforce. Friday’s volume equaled 54% of reported short interest, but the rally outpaced cost-cutting fundamentals, leaving less room for further gains based solely on headcount cuts.
Court ruling on student loans hits private lenders’ health grad loan push

Court ruling on student loans hits private lenders’ health grad loan push

27 June 2026
Judge blocks narrow “professional degree” rule, letting more health-care grad students keep higher federal loan caps; $7.87B in 2023-24 borrowing above new limits remains in federal market, trimming but not eliminating the $4.5B-$5B annual private loan growth Sallie Mae projected from Grad PLUS loan cuts.
US Economic Calendar Today: Stock Futures Hold Steady as Traders Eye Fed Speeches, Treasury Buyback and Delayed Jobs Data
Previous Story

US Economic Calendar Today: Stock Futures Hold Steady as Traders Eye Fed Speeches, Treasury Buyback and Delayed Jobs Data

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe
Next Story

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe

Go toTop